Canadian (TSX) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Feb 06, 2026

Discover Canadian Pharmaceuticals & Biotech Growth Stocks that are on the TSX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

149 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
OGI	CA$2.10	3.4%	-11.8%	CA$274.1m	CA$3.32	1.1	148.5%	n/a
HITI	CA$3.22	5.9%	-20.7%	CA$273.2m	CA$7.70	3.2	137.0%	n/a
DHB	CA$0.18	-10.0%	-10.0%	CA$5.6m	n/a	1.3	136.9%	n/a
TRUL	CA$9.48	0.9%	39.8%	CA$1.6b	CA$19.53	1.0	122.6%	n/a
XRTX	CA$0.58	-15.9%	-53.6%	CA$4.4m	n/a	1.5	98.6%	n/a
ACB	CA$4.77	-13.4%	-44.7%	CA$256.3m	CA$7.62	0.5	93.1%	n/a
PLTH	CA$0.23	0%	-53.9%	CA$70.6m	n/a	1.0	86.9%	n/a
LABS	CA$0.07	7.7%	0%	CA$29.7m	n/a	0.8	86.2%	n/a
TSND	CA$0.92	7.0%	-1.1%	CA$315.2m	CA$1.73	2.2	81.1%	n/a
VEXT	CA$0.28	-3.4%	80.6%	CA$70.3m	n/a	1.1	81.1%	n/a
VRNO	CA$1.69	0%	-0.6%	CA$613.9m	CA$4.39	0.5	70.0%	n/a
NGEN	CA$5.35	-1.7%	87.1%	CA$419.0m	CA$6.90	-16.7	67.6%	n/a
EDT	CA$1.30	4.0%	120.3%	CA$380.3m	CA$3.10	140.6	65.8%	n/a
SVA	CA$0.15	-3.1%	-26.2%	CA$52.6m	n/a	-3.3	61.5%	n/a
HLS	CA$4.50	0.2%	7.1%	CA$140.7m	CA$7.75	1.8	60.7%	0%
WEED	CA$1.51	0.7%	-47.8%	CA$574.4m	CA$3.20	2.0	59.5%	n/a
CRDL	CA$1.37	7.0%	-28.3%	CA$145.3m	CA$6.00	15.9	59.0%	n/a
MDP	CA$2.84	0.4%	-11.5%	CA$92.2m	CA$6.89	177.2	57.6%	n/a
GUD	CA$5.88	1.4%	2.8%	CA$579.3m	CA$7.93	1.4	54.0%	n/a
CURA	CA$3.27	8.6%	42.8%	CA$2.3b	CA$4.88	1.5	53.2%	n/a
CRON	CA$3.60	5.9%	29.5%	CA$1.3b	CA$4.15	28.0	28.3%	n/a
GTII	CA$9.89	9.3%	-3.7%	CA$2.2b	CA$17.49	38.4	26.8%	n/a
DB	CA$0.09	-10.0%	12.5%	CA$51.9m	n/a	4.4	26.0%	n/a
CL	CA$1.43	0.7%	3.6%	CA$620.3m	CA$2.43	0.9	25.6%	n/a

Page 1 of 7